Medline Inc

MDLN

Market cap $32.7B

Although the revenue and EPS for Medline (MDLN) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Medline Inc. (MDLN) Q1 2026 Earnings Call Transcript

Net sales of $7.4 billion, an increase of 10.7% Net income of $239 million, a decrease of 25.8% Adjusted EBITDA 1 of $776 million, a decrease of 10.6% Raising full year 2026 Organic Sales 2 guidance range to 8.5% to 9.5% NORTHFIELD, Ill., May 06, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline” or the “Company”) (Nasdaq: MDLN), the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care3, today reported its operating results for the three months ended March 28, 2026.

We are actively monitoring Meta Platforms' social and data privacy risks and believe the company has made progress on strengthening its policies and enforcement. We believe the market is underestimating the durability of Edwards' transcatheter aortic valve replacement franchise and the opportunity for its transcatheter mitral and tricuspid therapies. We exited our position in Workday to bring the portfolio's software exposure closer to market weight.

Continued investment in next-gen supply chain technology powers Medline's distribution capabilities NORTHFIELD, Ill., April 16, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) announced a strategic agreement to implement next-generation warehouse automation from Symbotic, a leader in AI-enabled robotics technology, as part of the company's ongoing efforts to strengthen the resiliency, efficiency and scalability of the healthcare supply chain.

During the quarter, we continued to broaden our portfolio's exposure away from companies more vulnerable to disruption from AI, toward companies with durable business models and clear paths to growth. We invested in Dick's Sporting Goods, a consistent share gainer that recently acquired Foot Locker, which we believe offers meaningful upside over the long term. We exited Ares Management, as recent liquidity pressures and credit concerns at several high-profile borrowers have increased scrutiny on the private credit asset class and could dampen fundraising and investor demand.

MDLN faces FDA warning over cGMP lapses in angiographic syringes, citing weak quality controls, CAPA gaps and design flaws despite escalating share price.

The U.S. Food and Drug Administration has warned medical device maker Medline that its syringes used in heart procedures are defective and that the ​company has failed to fix the problem adequately.

NORTHFIELD, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report first quarter 2026 financial results on Wednesday, May 6, 2026.

Investment in combined robotic, conveyor and packing technology supports the delivery of medical supplies directly to homes of health plan members  NORTHFIELD, Ill., April 6, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) has launched a fulfillment system called Pick Pack Pro™ at its distribution center in Montgomery, N.Y.